Conference Program Home
My Program
All Times EDT
Legend:
CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
271 * !
|
Tue, 8/9/2022,
10:30 AM -
12:20 PM
|
CC-207B
|
|
Recent Statistical Advances of Handling Nonproportional Hazards in Study Design and Data Interpretation — Topic Contributed Papers
|
|
Biopharmaceutical Section, Biometrics Section
|
|
Organizer(s): Philip He, Daiichi Sankyo
|
|
Chair(s): Xiaofei Chen, Sanofi
|
|
10:35 AM
|
Hypothesis Testing Under Non-Proportion Hazards: Methodologic Challenges and Interpretations
Jianghua He, University of Kansas Medical Center; Huan Cheng, University of Kansas Medical Center
|
|
10:55 AM
|
Adaptive Extension of Group-Sequential Time-to-Event Trials in the Presence of Non-Proportional Hazards
Yue Shentu, Daiichi Sankyo Inc.; Yu Li, Merck & Co; Xieyang Jia, Merck & Co
|
|
11:15 AM
|
Delayed Separation of OS and PFS Kaplan Meier Curves Occurs in the Majority of IO Trials: A Meta-Analysis of Phase III Studies with Anti-PD-(L)1 Therapy
Magdalena Watras, AstraZeneca; Philip He, Daiichi Sankyo; Nana Rokutanda, AstraZeneca; Jennifer Stocks, AstraZeneca
|
|
11:35 AM
|
Testing and Estimating Treatment Effect in the Presence of Delayed Onset of the Effect for Cancer Immunotherapies
Chang Yu, Vanderbilt University Medical Center; Xiang Huang, Vanderbilt University Medical Center; Hui Nian, Vanderbilt University Medical Center; Philip He, Daiichi Sankyo
|
|
11:55 AM
|
Discussant: ZHENZHEN XU, FDA
|
|
12:15 PM
|
Floor Discussion
|
Video Available to all JSM Registered Attendees. Please login to view.
|
